FDA puts heavy restrictions on Avandia

Share this article:

The Food and Drug Administration announced Wednesday that effective Nov. 18, 2011, Avandia will be pulled from retail pharmacy shelves due to the diabetes drug's cardiovascular threat to patients.

A 2007 analysis conducted by the Cleveland Clinic cardiologist Steven Nissen, M.D., found that those with type 2 diabetes who took Avandia (rosiglitazone) had a 40% increase in heart attack risk. Several other studies confirmed the risk.

Starting Nov. 18, only certified doctors will be able to prescribe the drug, and only to patients who have been alerted to the risks, who have already taken the drug safely, and who have found that other medications did not control their diabetes. These patients can obtain Avandia through mail-order pharmacies.

Several cardiologists have criticized the FDA for failing to act sooner.

"It's like a decade-long nightmare coming to an end," Nissen told USA Today. "Eleven years after this drug was introduced, it will be so restricted in access that virtually no one will be able to get it."

Share this article:

More in News

Breier named new CEO at Kindred

Breier named new CEO at Kindred

Kindred Healthcare announced Thursday that it has chosen a new top executive to lead its push toward creating a mammoth national brand. Benjamin A. Breier, the company's current president and ...

Proposed managed care rule could accelerate shift away from nursing home care, official suggests

Proposed managed care rule could accelerate shift away ...

Proposed regulations slated for early 2015 likely will affect how Medicaid managed care balances home- versus facility-based long-term care, news sources reported Wednesday.

Assisted living residents say 'homelike' setting not so important

Contrary to conventional wisdom, assisted living residents might not place a high value on how "homelike" their surroundings are, suggest findings out of St. Catherine University in St. Paul, MN.